Evaluation of the stage classification of anal cancer by the TNM 8th version versus the TNM 7th version.

作者: Olav Dahl , Mette Pernille Myklebust , Jon Espen Dale , Otilia Leon , Eva Serup-Hansen

DOI: 10.1080/0284186X.2020.1778180

关键词: Background dataMedicineStage (cooking)Stage classificationAnal cancerMEDLINEGeneral surgery

摘要: Background: The UICC TNM 7th edition introduced stage groups for anal cancer which in 2019 has not yet come into general use. new 8th from 2016 defines 7 sub-stages. Background data...

参考文章(22)
TNM classification of malignant tumours Published in <b>2010</b> in Chichester, West Sussex, UK ;Hoboken, NJ by Wiley-Blackwell. ,(1987) , 10.1007/978-3-642-82982-6
Franz Rödel, Ulrike Wieland, Ingeborg Fraunholz, Julia Kitz, Margret Rave-Fränk, Hendrik A. Wolff, Christian Weiss, Ralph Wirtz, Panagiotis Balermpas, Emmanouil Fokas, Claus Rödel, Human papillomavirus DNA load and p16INK4a expression predict for local control in patients with anal squamous cell carcinoma treated with chemoradiotherapy. International Journal of Cancer. ,vol. 136, pp. 278- 288 ,(2015) , 10.1002/IJC.28979
Jaffer A. Ajani, Kathryn A. Winter, Leonard L. Gunderson, John Pedersen, Al B. Benson, Charles R. Thomas, Robert J. Mayer, Michael G. Haddock, Tyvin A. Rich, Christopher G. Willett, Prognostic factors derived from a prospective database dictate clinical biology of anal cancer: the intergroup trial (RTOG 98-11). Cancer. ,vol. 116, pp. 4007- 4013 ,(2010) , 10.1002/CNCR.25188
Anne Gry Bentzen, Marianne G. Guren, Barthold Vonen, Eva H. Wanderås, Gunilla Frykholm, Tom Wilsgaard, Olav Dahl, Lise Balteskard, Faecal incontinence after chemoradiotherapy in anal cancer survivors: Long-term results of a national cohort Radiotherapy and Oncology. ,vol. 108, pp. 55- 60 ,(2013) , 10.1016/J.RADONC.2013.05.037
Otilia Leon, Marianne Guren, Oskar Hagberg, Bengt Glimelius, Olav Dahl, Hanne Havsteen, Gisela Naucler, Christer Svensson, Kjell Magne Tveit, Anders Jakobsen, Per Pfeiffer, Eva Wanderås, Tor Ekman, Birgitta Lindh, Lise Balteskard, Gunilla Frykholm, Anders Johnsson, Anal carcinoma - Survival and recurrence in a large cohort of patients treated according to Nordic guidelines Radiotherapy and Oncology. ,vol. 113, pp. 352- 358 ,(2014) , 10.1016/J.RADONC.2014.10.002
Anne Gry Bentzen, Lise Balteskard, Eva Hoff Wanderås, Gunilla Frykholm, Tom Wilsgaard, Olav Dahl, Marianne Grønlie Guren, Impaired health-related quality of life after chemoradiotherapy for anal cancer: late effects in a national cohort of 128 survivors. Acta Oncologica. ,vol. 52, pp. 736- 744 ,(2013) , 10.3109/0284186X.2013.770599
Leonard L. Gunderson, Jennifer Moughan, Jaffer A. Ajani, John E. Pedersen, Kathryn A. Winter, Al B. Benson, Charles R. Thomas, Robert J. Mayer, Michael G. Haddock, Tyvin A. Rich, Christopher G. Willett, Anal carcinoma: Impact of TN category of disease on survival, disease relapse, and colostomy failure in US gastrointestinal intergroup RTOG 98-11 phase 3 trial International Journal of Radiation Oncology Biology Physics. ,vol. 87, pp. 638- 645 ,(2013) , 10.1016/J.IJROBP.2013.07.035
Anne Gry Bentzen, Marianne G. Guren, Eva H. Wanderås, Gunilla Frykholm, Kjell M. Tveit, Tom Wilsgaard, Olav Dahl, Lise Balteskard, Chemoradiotherapy of Anal Carcinoma: Survival and Recurrence in an Unselected National Cohort International Journal of Radiation Oncology*Biology*Physics. ,vol. 83, pp. e173- e180 ,(2012) , 10.1016/J.IJROBP.2011.12.062
Eva Serup-Hansen, Dorte Linnemann, Wojciech Skovrider-Ruminski, Estrid Høgdall, Poul Flemming Geertsen, Hanne Havsteen, Human Papillomavirus Genotyping and p16 Expression As Prognostic Factors for Patients With American Joint Committee on Cancer Stages I to III Carcinoma of the Anal Canal Journal of Clinical Oncology. ,vol. 32, pp. 1812- 1817 ,(2014) , 10.1200/JCO.2013.52.3464
Duncan C Gilbert, Eva Serup-Hansen, Dorte Linnemann, Estrid Høgdall, Charles Bailey, Jeff Summers, Hanne Havsteen, Gareth J Thomas, Tumour-infiltrating lymphocyte scores effectively stratify outcomes over and above p16 post chemo-radiotherapy in anal cancer British Journal of Cancer. ,vol. 114, pp. 134- 137 ,(2016) , 10.1038/BJC.2015.448